greeksoup/ stock research
Stock research / United States / Funds / Whitefort Capital Management, LP

Whitefort Capital Management, LP

CIK 1884931 · latest 13F filed 14 August 2026 · Read the filing on EDGAR

Whitefort Capital Management, LP reported 18 US-listed holdings worth $391.6 million in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Arbutus Biopharma Corp. (19.4%), Roivant Sciences Ltd. (9.2%) and Joyy Inc. (8.8%). Against the quarter before, it opened 2 positions, added to 6, trimmed 4 and sold out of 2.

Reported holdings$391.6M+23.6% on Q1 2026
Positions18as many as Q1 2026
The largest ten81.3%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Where the money is
OpenedAdded toHeldTrimmed
ABUS19.4%ROIV9.2%JOYY8.8%BALY8.4%GNW7.6%NN7.3%OABI6.4%ZD5.6%TDAY4.4%CDZI4.3%SGRY3.9%PUBM3.7%VATE3.5%SOC2.9%4 more4.6%

The 14 largest of its 18 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $203.0 million in 15 positions$203MQ3 24Q4 2024: $192.1 million in 15 positions$192MQ4 24Q1 2025: $185.4 million in 12 positions$185MQ1 25Q2 2025: $239.3 million in 15 positions$239MQ2 25Q3 2025: $287.7 million in 15 positions$288MQ3 25Q4 2025: $318.0 million in 16 positions$318MQ4 25Q1 2026: $316.9 million in 18 positions$317MQ1 26Q2 2026: $391.6 million in 18 positions$392MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +90.5% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
90120150180Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings +90.5%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 2Added 6Held 6Trimmed 4Sold out 2
Opened: 2Added: 6Held: 6Trimmed: 4Sold out: 2

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 2

  1. Ziff Davis, Inc. ZD$21.9 million
  2. Doubledown Interactive Co. LT DDI$6.3 million

Added to 6

  1. Nextnav Inc. NN+1.5 million shares · +2531%
  2. Sable Offshore Corp. SOC+2.2 million shares · +141%
  3. Pubmatic Inc. PUBM+420,656 shares · +61%
  4. Arbutus Biopharma Corp. ABUS+863,376 shares · +6%
  5. Outbrain Inc. TEAD+999,060 shares · +28%
  6. Opko Health Inc. OPK+258,072 shares · +6%

Trimmed 4

  1. Roivant Sciences Ltd. ROIV-400,000 shares · -28%
  2. Omniab, Inc. OABI-4.0 million shares · -28%
  3. Gannett Co. Inc. TDAY-1.1 million shares · -36%
  4. Surgery Partners Inc. SGRY-9,804 shares · -1%

Sold out of 2

  1. Uniqure NV QURE$10.8 million last quarter
  2. Nextnav Inc. NNAVW$299,181 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Arbutus Biopharma Corp. ABUS15.8M$75.8 million19.36%+863.4K
Roivant Sciences Ltd. ROIV1.0M$36.1 million9.21%-400.0K
Joyy Inc. JOYY524.9K$34.6 million8.85%no change
Ballys Corporation BALY2.4M$33.0 million8.43%no change
Genworth Financial Inc. GNW3.1M$29.6 million7.57%no change
Nextnav Inc. NN1.6M$28.5 million7.27%+1.5M
Omniab, Inc. OABI10.2M$25.2 million6.44%-4.0M
Ziff Davis, Inc. ZD418.4K$21.9 million5.59%new
Gannett Co. Inc. TDAY2.0M$17.1 million4.38%-1.1M
Cadiz Inc. CDZI4.0M$16.7 million4.26%no change
Surgery Partners Inc. SGRY901.3K$15.1 million3.87%-9.8K
Pubmatic Inc. PUBM1.1M$14.6 million3.72%+420.7K
Innovate Corp. VATE743.0K$13.9 million3.54%no change
Sable Offshore Corp. SOC3.7M$11.5 million2.93%+2.2M
Opko Health Inc. OPK4.5M$6.8 million1.73%+258.1K
Doubledown Interactive Co. LT DDI546.2K$6.3 million1.60%new
Outbrain Inc. TEAD4.6M$3.5 million0.90%+999.1K
Kestrel Group Ltd KG160.9K$1.4 million0.37%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 2 it sold out of are in the box above.